Colombia
Tuberculosis profile
Population  2012 48 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.77 (0.76–0.79) 1.6 (1.6–1.6)
Mortality (HIV+TB only) 0.38 (0.31–0.46) 0.8 (0.66–0.96)
Prevalence  (includes HIV+TB) 23 (11–39) 48 (22–83)
Incidence  (includes HIV+TB) 16 (13–19) 33 (27–39)
Incidence (HIV+TB only) 1.6 (1.3–1.9) 3.3 (2.7–4)
Case detection, all forms (%) 73 (61–88)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 6 523 (59) Relapse 358 (47)
Smear-negative 1 733 (16) Treatment after failure 44 (6)
Smear-unknown / not done 546 (5) Treatment after default 361 (47)
Extrapulmonary 2 264 (20) Other 0 (0)
Other 0 (0)      
Total new 11 066   Total retreatment 763  
           
Other (history unknown) 0        
Total new and relapse 11 424   Total cases notified 11 829  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.5 1.3 1.7
Age < 15 171 323 127
Laboratories 2012
Smear (per 100 000 population) 5.6
Culture (per 5 million population) 124.6
Drug susceptibility testing (per 5 million population) 0.4
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 77   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 67  
Retreatment 45  
TB/HIV 2012 Number (%)
TB patients with known HIV status 7 791 (66)
HIV-positive TB patients 1 400 (18)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART) 474 (34)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.4 (1.6–3.6) 13 (9.6–17)
MDR-TB cases among notified pulmonary
TB cases
210 (140–320) 98 (74–130)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 2 378 (33%) 391 (51%) 2 797
Laboratory-confirmed MDR-TB cases 55 50 105
Patients started on MDR-TB treatment     76
Financing TB control 2013
National TB programme budget (US$ millions) 11
% Funded domestically 60%
% Funded internationally 21%
% Unfunded 19%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-17 Data: www.who.int/tb/data